For the Inventor, By the Inventor

Enter assignee name

Los Angeles, CA, United States of America

Ritter Pharmaceuticals, Inc.

USPTO Granted Patents = 12

% Expired Patents = 75.0

CIPO Patents = 1

EPO Patents = 1

Forward Citations = 95

Loading Chart...

Loading Chart...

10 inventors (with patents filed for the assignee):

Andrew J Ritter (10 out of 11 patents)

David M Barnes (8 out of 34 patents)

Dennis Savaiano (8 out of 8 patents)

4. Todd Robert Klaenhammer (8 out of 40 patents)

5. Giovanni Cipolletti (2 out of 19 patents)

6. Silvia Giacomelli (2 out of 3 patents)

7. Marco Manoni (2 out of 6 patents)

8. Silvia Biagiolini (2 out of 3 patents)

9. Luana Vagnoli (2 out of 5 patents)

10. Jacopo Chini (2 out of 5 patents)

12 patents: Sort by Forward Citations

1. 11028422 - Process for the production of ultrapure galacto-oligosaccharides (2021-06-08),

2. 9808481 - Prebiotic formulations and methods of use (2017-11-07),

3. 9775860 - Prebiotic formulations and methods of use (2017-10-03),

4. 9592248 - Prebiotic formulations and methods of use (2017-03-14),

5. 9579340 - Prebiotic formulations and methods of use (2017-02-28),

6. 9370532 - Prebiotic formulations and methods of use (2016-06-21),

7. 9226933 - Methods and compositions for treating lactose intolerance (2016-01-05),

8. 9200303 - Process for the production of ultrapure galacto-oligosaccharides (2015-12-01),

9. 8785160 - Prebiotic formulations and methods of use (2014-07-22),

10. 8492124 - Prebiotic formulations and methods of use (2013-07-23),

11. 8486668 - Prebiotic formulations and methods of use (2013-07-16),

12. 7879363 - Method for increasing lactose tolerance in mammals exhibiting lactose intolerance (2011-02-01),

Ritter Pharmaceuticals, Inc. is a biotechnology company focused on the development and commercialization of novel therapeutic products that modulate the human gut microbiome. The company aims to improve the gut health of individuals by addressing gastrointestinal diseases and disorders. Ritter Pharmaceuticals is committed to utilizing its expertise in microbiome science to create innovative treatments for conditions such as lactose intolerance, Crohn's disease, and irritable bowel syndrome. Through its cutting-edge research and development efforts, Ritter Pharmaceuticals is dedicated to improving the lives of patients worldwide.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

12 Patents

#166 in Los Angeles, CA

#6,055 in California

#25,526 in US

#48,090 in the World

Los Angeles, CA, United States of America

Ritter Pharmaceuticals, Inc.

Forward Citations = 95

10 inventors:

Andrew J Ritter (10 out of 11 patents)

David M Barnes (8 out of 34 patents)

Dennis Savaiano (8 out of 8 patents)

4. Todd Robert Klaenhammer (8 out of 40 patents)

5. Giovanni Cipolletti (2 out of 19 patents)

Please report any incorrect information to [email protected]

Loading…